Document:

Nonqualified Stock Option Agreement (Non-Employee Director)

 EXHIBIT 10.13 
  
 IVAX DIAGNOSTICS, INC. 
 Nonqualified Stock Option Agreement 
 (Non-Employee Director) 
  
 1. Grant of Option. In accordance with and subject to the terms and conditions
of (A) the IVAX Diagnostics, Inc. 1999 Performance Equity Plan, as it may be amended from time to time (the “Plan”), a copy of which is attached hereto as Exhibit A and (B) this Nonqualified Stock Option Agreement (the
“Agreement”), IVAX Diagnostics, Inc., a Delaware corporation (the “Company”), grants to the optionee identified on Schedule 1 attached hereto (the “Optionee”) a nonqualified stock option (the
“Option”) to purchase the number of shares (the “Shares”) of the Company’s Common Stock, par value $0.01 per share, set forth on Schedule 1, at the option price set forth in Schedule 1. 
  
 2. Acceptance by Optionee. The exercise of the Option or any portion thereof is
conditioned upon acceptance by the Optionee of the terms and conditions of this Agreement, as evidenced by the Optionee’s execution of Schedule 1 to this Agreement and the delivery of an executed copy of Schedule 1 to the Company. 

 
 3. Vesting of Option. The Option shall become exercisable in accordance with
the vesting schedule set forth in Schedule 1. 
  
 4. Expiration of
Option. The Option shall expire on the date set forth in Schedule 1, and may not be exercised after such date. 
  
 5. Procedure for Exercise. The Option may be exercised for the number of Shares specified in a written notice delivered to the Company at least ten (10)
days prior to the date on which purchase is requested, accompanied by full payment for the Shares with respect to which the Option is being exercised, in the manner and subject to the terms and conditions set forth in the Plan. Notwithstanding the
foregoing, the Option may not be exercised as to less than ten (10) Shares at any time, or, if less than ten (10) Shares, the number of Shares subject to the Option. If any applicable law requires the Company to take any action with respect to the
Shares specified in such notice, or if any action remains to be taken under the Certificate of Incorporation or Bylaws of the Company, as they may be amended from time to time, to effect due issuance of the Shares, then the Company shall take such
action, and the day for delivery of such Shares shall be extended for the period necessary to take such action. Neither the Optionee nor any other person entitled to exercise the Option shall be or have any rights or privileges of, a stockholder of
the Company in respect of any of the Shares issuable upon exercise of the Option, unless and until the Shares are issued to the Optionee. 
  
 6. No Right to Employment. The issuance of the Option or any Shares pursuant to the Option shall not give the Optionee any right to be employed or retained
in the employ of the Company. 

 7. Representations as to Purchase of Shares. As a condition of the Company’s obligation to issue
Shares upon exercise of the Option, if requested by the Company, the Optionee shall, concurrently with the delivery of the stock certificate representing the Shares so purchased, give such written assurances to the Company, in the form and substance
that its counsel reasonably requests, to the effect that the Optionee is acquiring the Shares for investment and without any present intention of reselling or redistributing the same in violation of any applicable law. In the event that the Company
elects to register, or has registered, the Shares under the Securities Act of 1933 and any applicable state laws, the issuance of such Shares shall not be subject to the restrictions contained in this paragraph 7. 
  
 8. Compliance with Applicable Law. The issuance of the Shares pursuant to the
exercise of this Option is subject to compliance with all applicable laws, including, without limitation, laws governing withholding from employees and nonresident aliens for income tax purposes. 
  
 IN WITNESS WHEREOF, the Company has caused this Agreement to be
executed as of the Date of Grant set forth in Schedule 1. 
  

			
	IVAX DIAGNOSTICS, INC.
		
	By:	 	  

	Name:	 	  

	Title:	 	  

  

 2 

 Schedule 1 
  
 Nonqualified Stock Option Agreement 
 (Non-Employee Director) 
  
 Name of
Optionee: 
  
 Number of Shares: 
  
 Option Price Per Share: 
  
 Date of Grant: 
  
 Expiration Date: 
  
 Vesting Schedule: 
  
 The undersigned agrees to the terms and conditions of the Nonqualified Stock Option Agreement
of which this Schedule 1 is a part, and acknowledges receipt of the prospectus relating to the Plan and of the Company’s most recent annual report to stockholders. 
  

					
	Date Accepted:	 	  

	  	  

 Optionee

			
	 	 	 	  	  

 Social
Security NumberExecutive Severance Pay Plan dated February 1, 2005

  
 Exhibit 10.11

  
 UNIVERSAL HOSPITAL SERVICES, INC. 
 EXECUTIVE SEVERANCE PAY PLAN 
  
 February 1, 2005 
  
 I. Purpose. 
  
 To provide a severance pay plan for the Executives (as defined below) of the Company who are not eligible for severance pay under any other plan or
agreement with the Company. The provisions of this plan will not apply to any Executive who is covered by an employment agreement. Executives who receive severance under this plan will not be eligible to receive severance under any other plan or
agreement of the Company. No severance benefits become payable pursuant to this plan in the event of termination of employment upon an Executive’s death or disability. This plan replaces the Executive Severance Pay Plan dated January 25, 2001.

  
 II. Definitions. 
  
 A. “Cause” means: 
  

	 	(i)	Executive’s continued failure, whether willful, intentional or grossly negligent, after written notice, to perform substantially Executive’s duties (the
“Duties”) as determined by immediate supervisor, (Chief Executive Officer or Senior Vice President of the Company (other than as a result of a disability); 

  

	 	(ii)	dishonesty in the performance of Executive’s Duties; 

  

	 	(iii)	conviction or confession of an act or acts on Executive’s part constituting a felony under the laws of the United States or any state thereof; or 

  

	 	(iv)	any other willful act or omission on Executive’s part which is materially injurious to the financial condition or business reputation of the Company or any of its subsidiaries.

  
 B. “Change of Control” means (i) any
event as a result of which J.W. Childs and Halifax collectively cease to own and control all of the economic and voting rights associated with ownership of at least 50.1% of the outstanding capital stock of Company; or (ii) any sale or transfer of
all or substantially all of the assets of the Company. 
  
 C.
“Change of Control Period” means the period starting 30 days before the Change in Control and continuing through 6 months after the Change in Control. 
  

 D. “Date of Termination” means the date specified as Executive’s last date of employment
in the Company’s notice of termination to Executive or Executive’s Notice of Resignation for Good Cause to the Company. 
  
 E. “Resignation For Good Cause” means: Executive termination of employment upon 30 days’ written notice to the company, for Good Cause.
Executive shall have “Good Cause” for termination of employment if, other than for cause, any of the following has occurred: 
  

	 	(i)	the Company has reduced or reassigned a material portion of Executive duties (per Executive job description); 

  

	 	(ii)	the Executive’s base salary has been reduced other than in connection with an across-the-board reduction (of approximately the same percentage) in executive compensation to
Executive Employees imposed by the Board in response to negative financial results or other adverse circumstances affecting the Company; or 

  

	 	(iii)	the Company has required Executive to relocate in excess of fifty (50) miles from the location where the Executive is currently employed. 

  
 F. “Executive” means the President, any Senior Vice President, any
Vice President of the Company, the Controller and the General Counsel as such titles are in use effective February 1, 2005. 
  
 G. “Severance Period” means the period from the Date of Termination through the date, which is 12 months from the Date of Termination.

  
 III. Severance Pay. 
  
 A. Executives who separate from the Company and who sign the general release
and other agreement described in Section IV below are entitled to the severance pay specified below; provided, however, that (1) an Executive who is separated from employment due to dismissal for Cause is not entitled to any severance pay; (2) an
Executive who voluntarily resigns, except for Good Cause, from employment is not entitled to severance pay; and (3) the Controller and General Counsel are entitled to the severance pay specified below only if terminated by the Company during the
Change of Control Period, but the Controller and General Counsel are not entitled to any severance pay if terminated for Cause. 
  
 B. Upon qualifying for severance pay, Executive will be paid the following amounts in the following manner: 
  

	 	(i)	Executive will continued to be paid his or her base salary through the Severance Period, in the manner and at the times paid during such Executive’s employment with the
Company. 

  

	 	(ii)	Company shall pay the Executive a lump sum payment equal to the cost continuing the Executive’s existing family medical and dental insurance benefits pursuant to Consolidated
Omnibus Budget Reconciliation Act of 1985 (COBRA) for the duration of the Severance Period. 

  

	 	(iii)	If prior to the date which is 12 months after the Date of Termination, Executive finds other employment, the amount of severance payments payable to Executive after such termination
in accordance with B(i) above will be reduced by the value of the compensation Executive receives in his or her new employment through the date which is 12 months after the Date of Termination; B(ii) shall be similarly discontinued if similar
medical and dental benefits are secured with new employer through the date which is 12 months after the Date of Termination. 

  

	 	(iv)	If termination is pursuant to Resignation for Good Cause, The Company shall provide the Executive a prorated portion of the bonus earned for the then current fiscal year, based upon
the number of days Executive was employed during that year. Such Executive bonus shall be payable at the time annual bonuses are paid to the other executives employed by the Company, on the last day of the Company’s fiscal year.

  

	 	(v)	Executive will be paid or otherwise provided such other benefits as may be required by law. 

  

	 	(vi)	All severance payments are subject to any required withholding. 

  
 IV. General Release and Other Agreements. 
  
 Executive will not be entitled to receive any of the severance pay described above until such time as Executive signs (A) an effective general release of
all claims against the Company and its affiliates in the form and manner prescribed by the Company and (B) an agreement further providing (i) Executive’s agreement not to disclose or use confidential information of the Company, (ii)
Executive’s agreement during the Severance Period not to compete with the Company in the medical equipment rental business, (iii) Executive’s agreement during the Severance Period not to solicit for employment or hire any employee of the
Company, and (iv) Executive’s agreement during the Severance Period not to solicit as a customer or client of medical equipment rental business and customer or client of the Company. A failure to execute such a general release and other
agreements within one month of Executive’s Date of Termination shall result in the loss of any rights to receive payments or benefits under this plan. 
  
 V. Amendment and Modification of Plan. This plan may be modified, amended or terminated at any time by the CEO and the Board of Directors of
the Company. 
  
 VI. No Employment Rights. Neither this
plan for the benefits hereunder shall be a term of the employment of any employee, and the Company shall not be obligated in any way to continue the plan. The terms of this plan shall not give any employee the right to be retained in the employment
of the Company.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00082-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00082-of-00352.parquet"}]]